MX9605030A - Terapia de combinacion antiemetica usando antagonistas de receptor nk-1. - Google Patents

Terapia de combinacion antiemetica usando antagonistas de receptor nk-1.

Info

Publication number
MX9605030A
MX9605030A MX9605030A MX9605030A MX9605030A MX 9605030 A MX9605030 A MX 9605030A MX 9605030 A MX9605030 A MX 9605030A MX 9605030 A MX9605030 A MX 9605030A MX 9605030 A MX9605030 A MX 9605030A
Authority
MX
Mexico
Prior art keywords
combination
receptor antagonists
antiemetic therapy
antiemetic
therapy
Prior art date
Application number
MX9605030A
Other languages
English (en)
Other versions
MXPA96005030A (es
Inventor
Susan F Gonsalves
Sandra L Silberman
John W Watson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX9605030A publication Critical patent/MX9605030A/es
Publication of MXPA96005030A publication Critical patent/MXPA96005030A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invencion se refiere a procedimientos de tratamiento o prevencion de la emesis en mamíferos, incluyendo a humanos, usando un antagonista de NK-1 en combinacion con uno o más agentes activos diferentes seleccionados entre (a) un glucocorticoide o corticoesteroide, (b) una benzodiacepina, (c) metaclopramida y (d) un depurador molecular intracelular.
MXPA/A/1996/005030A 1995-10-20 1996-10-21 Terapia de combinacion antiemetica usando antagonistas de receptor nk-1 MXPA96005030A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US005728 1987-01-21
US572895P 1995-10-20 1995-10-20

Publications (2)

Publication Number Publication Date
MX9605030A true MX9605030A (es) 1997-09-30
MXPA96005030A MXPA96005030A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
NZ299606A (en) 2000-07-28
EP0769300A3 (en) 1999-11-24
CA2188227A1 (en) 1997-04-21
CA2188227C (en) 2000-08-08
AU700841B2 (en) 1999-01-14
CN1151893A (zh) 1997-06-18
JPH09110721A (ja) 1997-04-28
TW458774B (en) 2001-10-11
IL119418A (en) 2001-07-24
IL119418A0 (en) 1997-01-10
ZA968790B (en) 1998-04-20
AU7027996A (en) 1997-05-15
EP0769300A2 (en) 1997-04-23

Similar Documents

Publication Publication Date Title
YU59098A (sh) Derivati spiro-piperidina, postupak njihovog dobijanja, njihova upotreba u proizvodnji leka korisnog za lečenje ili prevenciju bolova, upalnih procesa, migrene, povraćanja i postherpetične neuralgije i farmaceutski sastav koji ih sadrži
MX9703186A (es) Antagonistas del receptor del neuropeptido y de indolilo.
MXPA99001870A (es) Antagonistas del receptor de taquicinina,no peptidicos.
MY116002A (en) Nk-1 receptor antagonists and 5ht3 receptor antagonists for the treatment of emesis
MX9704640A (es) Compuesto moduladores de los receptores de los esteroides y metodos para su preparacion.
MY131434A (en) Angiotensin ii antagonists
DE69528823D1 (en) Morpholinwirkstoffvorläufer als tachykininreceptorantagonisten
EP1382597A3 (en) Steroid receptor modulator compounds and methods
AU1753699A (en) Application of vasopressin antagonists for treating disturbances or illnesses ofthe inner ear
IL142921A0 (en) USES FOR Eph RECEPTOR ANTAGONISTS AND AGONISTS TO TREAT VASCULAR DISORDERS
UA42806C2 (uk) Система для одночасного трансдермального введення кількох активних начал
MX9603259A (es) Tratamiento de glaucoma normotensivo con antagonistas de angiotensina ii.
MY115310A (en) Substance p antagonists for the treatment of emesis
PL316754A1 (en) Insecticidal mixtures of artificial fertilisers
NZ333723A (en) A synergistic combination of an insulin resistance improving agent and an angiotensin II receptor antagonist or an angiotensin converting enzyme inhibitor
DK0615751T3 (da) Anvendelse af tachykininantagonister til behandling af emesis
BR0311898A (pt) Tratamento de associação para depressão e ansiedade com antagonistas de nk1 e nk3
AU1667500A (en) N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthal necarboxamides and their use as neurokinin 1 (nk1) and/or neurokinin 2 (nk2) receptor antagonists
ATE381533T1 (de) Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung
WO1999038532A3 (en) Methods for the prevention and treatment of fibrosis and sclerosis
BG105761A (en) Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
GR3023021T3 (en) Synergising association having an antagonist effect on nk1 and nk2 receptors.
BG105962A (en) Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders
EP1166783A3 (en) Tetrahydrobenz[CD]indole-6-carboxamides for treating sexual dysfunction
MX9605030A (es) Terapia de combinacion antiemetica usando antagonistas de receptor nk-1.